Jefferies Maintains a 'Buy' on Varian Medical (VAR); Still Struggling Domestically but VAR Remains A Safe Bet

Jefferies maintains a 'Buy' on Varian Medical (NYSE: VAR) price target raised from $72 to $77.

Analyst, Raj Denhoy, said, "A mixed FQ1 with revenues $8mn light but EPS ahead by $0.04 on a GM rebound, favorable product mix, and lower share count. F12 guidance largely intact, although sequential outlook a touch light on oncology order deal slippage. Shares could take a breather, but continued strong global demand, positive product cycle, and potential kicker from Siemens (NYSE: SI) exiting the market remain reasons to own VAR."

(Jefferies lowers FY12 EPS estimate from $3.98 to $3.95, but raises FY13 from $4.40 to $4.56)

For an analyst ratings summary and ratings history on Varian Medical click here. For more ratings news on Varian Medical click here.

Shares of Varian Medical closed at $69.24 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Bernstein SocGen on Walmart (WMT): 'We recommend buying on weakness'